Objective: To observe and analyze the changes in muscle mass in patients with Sjogren’s syndrome and sarcopenia. Methods: From October 2016 to December 2018, the muscle mass of 31 female patients with Sjogren’s syndrome who underwent DXA testing in Linyi City People’s Hospital was tested, and the changes in muscle mass of patients with Sjogren’s syndrome were investigated. Results: The incidence of decreased skeletal muscle mass in patients with Sjogren’s syndrome was lower. The upper and lower limbs of patients with decreased skeletal muscle mass were significantly lower than those with normal skeletal muscle mass (P < 0.01). Conclusion: Patients with Sjogren’s syndrome will be accompanied by the loss of skeletal muscle mass. This damage can cause the patient’s exercise capacity to be limited, so adequate attention should be paid clinically.
Cite this paper
Zhang, Y. and Wang, M. (2020). Analysis of 31 Cases of Female Sjogren’s Syndrome Patients with Changes in Muscle Mass. Open Access Library Journal, 7, e6872. doi: http://dx.doi.org/10.4236/oalib.1106872.
Ournadre, A., Jaffeux, P., Frayssac, T., et al. (2017) SAT0682 Prevalence of Sarcopenia in Patients with Chronic Inflammatory Rheumatic Diseases. Annals of the Rheumatic Diseases, 76, 1033.
https://doi.org/10.1136/annrheumdis-2017-eular.5122
Santos, M.J., Vinagre, F., da Silva, J.C., et al. (2011) Body Composition Phenotypes in Systemic Lupus Erythematosus and Rheumatoid Arthritis: A Comparative Study of Caucasian Female Patients. Clinical and Experimental Rheumatology, 29, 470-476.
Chen, L.K., Woo, J., Assantachai, P., et al. (2020) Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment. Journal of the American Medical Directors Association, 21, 300-307.
https://doi.org/10.1016/j.jamda.2019.12.012
Espitia-Thibaulta, A., Masseaua, A., Néela, A., et al. (2017) Sjögren’s Syndrome-Associated Myositis with Germinal Centre-Like Structures. Autoimmunity Reviews, 16, 154-158. https://doi.org/10.1016/j.autrev.2016.12.006
Li, Y., Wu, L. and Chen, Q. (2001) Clinical and Pathological Changes of Neuromuscular Complications in 7 Sjogren’s Syndrome Cases. Chinese Journal of Neurology, 34, 344-346.
Kanda, K. and Hashizume, K. (1991) Recovery of Motor-Unit Function after Peripheral Nerve Injury in Aged Rats. Neurobiology of Aging, 12, 271-276.
https://doi.org/10.1016/0197-4580(91)90002-2
Vasilaki, A., Pollock, N., Giakoumaki, I., et al. (2016) The Effect of Lengthening Contractions on Neuromuscular Junction Structure in Adult and Old Mice. AGE, 38, 259-272. https://doi.org/10.1007/s11357-016-9937-7
Santo, R.C.E., Fernandes, K.Z., Lora, P.S., et al. (2018) Prevalence of Rheumatoid Cachexia in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis. Journal of Cachexia, Sarcopenia and Muscle, 9, 816-825. https://doi.org/10.1002/jcsm.12320
Little, R.D., Prieto-Potin, I., Pérez-Baos, S., et al. (2017) Compensatory Anabolic Signaling in the Sarcopenia of Experimental Chronic Arthritis. Scientific Reports, 7, 6311. https://doi.org/10.1038/s41598-017-06581-6
Yang, J., Liu, J., Zhang, J.S., et al. (2012) Impacts of Xinfeng Capsules on the Expressions of IL-10,TNF-α and IL-17 for the Rats with Sjogren Syndrome. World Journal of Integrated Traditional and Western Medicine, 7, 206-209.
Phillips, T. and Leeuwenburgh, C. (2005) Muscle Fiber Specific Apoptosis and TNF-Alpha Signaling in Sarcopenia Are Attenuated by Life-Long Calorierestriction. FASEB Journal, 19, 668-670. https://doi.org/10.1096/fj.04-2870fje
Cao, J.Q., Zhao, L.J., Xiao, W.G., et al. (2006) Effect of Hydroxychloroquine on IL-1β and TNF-α in Non-Obese Diabetic Mice with Sjogren’s Syndrome. Chinese Journal of Rheumatology, 10, 542-546, 578.
